Common Contracts
14 similar Subscription Agreement contracts by Constellation Alpha Capital Corp.
SUBSCRIPTION AGREEMENTSubscription Agreement • August 2nd, 2019 • Constellation Alpha Capital Corp. • Services-medical laboratories • New York
In connection with the proposed business combination (the “Transaction”) in which DermTech, Inc., a Delaware Corporation (“DermTech”) will merge with a wholly-owned subsidiary corporation of Constellation Alpha Capital Corp., a company incorporated in the British Virgin Islands and which is expected to re-domicile in the State of Delaware (the “Company”), the undersigned desires to subscribe for and purchase from the Company, and the Company desires to sell to the undersigned, that number of shares of common stock (the “Company Shares”) of the Company set forth on the signature page hereof for a purchase price of $3.25 per share, on the terms and subject to the conditions contained herein. In connection therewith, the undersigned and the Company agree as follows:
FIRST AMENDED AND RESTATED SUBSCRIPTION AGREEMENTSubscription Agreement • August 2nd, 2019 • Constellation Alpha Capital Corp. • Services-medical laboratories • New York
This First Amended and Restated Subscription Agreement, which amends and restates in its entirety that certain Subscription Agreement, dated as of May 22, 2019 (as amended, and as may be further amended and/or restated, this “Subscription Agreement”), is made by and between Constellation Alpha Capital Corp., a company incorporated in the British Virgin Islands and which is expected to re-domicile in the State of Delaware (the “Company”), and the undersigned, who desires to subscribe for and purchase from the Company, and the Company desires to sell to the undersigned, that number of (i) shares of common stock (the “Common Shares”) of the Company and (ii) shares of Series A preferred stock (the “Preferred Shares” and, together with the Common Shares, the “Company Shares”) of the Company, where each Preferred Share is convertible into 1,000 Common Shares, set forth on the signature page hereof for a purchase price of $3.25 per Common Share and $3,250 per Preferred Share, on the terms and
FIRST AMENDED AND RESTATED SUBSCRIPTION AGREEMENTSubscription Agreement • August 2nd, 2019 • Constellation Alpha Capital Corp. • Services-medical laboratories • New York
This First Amended and Restated Subscription Agreement, which amends and restates in its entirety that certain Subscription Agreement, dated as of May 22, 2019 (as amended, and as may be further amended and/or restated, this “Subscription Agreement”), is made by and between Constellation Alpha Capital Corp., a company incorporated in the British Virgin Islands and which is expected to re-domicile in the State of Delaware (the “Company”), and the undersigned, who desires to subscribe for and purchase from the Company, and the Company desires to sell to the undersigned, that number of (i) shares of common stock (the “Common Shares”) of the Company and (ii) shares of Series A preferred stock (the “Preferred Shares” and, together with the Common Shares, the “Company Shares”) of the Company, where each Preferred Share is convertible into 1,000 Common Shares, set forth on the signature page hereof for a purchase price of $3.25 per Common Share and $3,250 per Preferred Share, on the terms and
SUBSCRIPTION AGREEMENTSubscription Agreement • August 2nd, 2019 • Constellation Alpha Capital Corp. • Services-medical laboratories • New York
In connection with the proposed business combination (the “Transaction”) in which DermTech, Inc., a Delaware Corporation (“DermTech”) will merge with a wholly-owned subsidiary corporation of Constellation Alpha Capital Corp., a company incorporated in the British Virgin Islands and which is expected to re-domicile in the State of Delaware (the “Company”), the undersigned desires to subscribe for and purchase from the Company, and the Company desires to sell to the undersigned, that number of shares of common stock (the “Company Shares”) of the Company set forth on the signature page hereof for a purchase price of $3.25 per share, on the terms and subject to the conditions contained herein. In connection therewith, the undersigned and the Company agree as follows:
FIRST AMENDED AND RESTATED SUBSCRIPTION AGREEMENTSubscription Agreement • August 2nd, 2019 • Constellation Alpha Capital Corp. • Services-medical laboratories • New York
This First Amended and Restated Subscription Agreement, which amends and restates in its entirety that certain Subscription Agreement, dated as of May 22, 2019 (as amended, and as may be further amended and/or restated, this “Subscription Agreement”), is made by and between Constellation Alpha Capital Corp., a company incorporated in the British Virgin Islands and which is expected to re-domicile in the State of Delaware (the “Company”), and the undersigned, who desires to subscribe for and purchase from the Company, and the Company desires to sell to the undersigned, that number of (i) shares of common stock (the “Common Shares”) of the Company and (ii) shares of Series A preferred stock (the “Preferred Shares” and, together with the Common Shares, the “Company Shares”) of the Company, where each Preferred Share is convertible into 1,000 Common Shares, set forth on the signature page hereof for a purchase price of $3.25 per Common Share and $3,250 per Preferred Share, on the terms and
SUBSCRIPTION AGREEMENTSubscription Agreement • August 2nd, 2019 • Constellation Alpha Capital Corp. • Services-medical laboratories • New York
In connection with the proposed business combination (the “Transaction”) in which DermTech, Inc., a Delaware Corporation (“DermTech”) will merge with a wholly-owned subsidiary corporation of Constellation Alpha Capital Corp., a company incorporated in the British Virgin Islands and which is expected to re-domicile in the State of Delaware (the “Company”), the undersigned desires to subscribe for and purchase from the Company, and the Company desires to sell to the undersigned, that number of shares of common stock (the “Company Shares”) of the Company set forth on the signature page hereof for a purchase price of $3.25 per share, on the terms and subject to the conditions contained herein. In connection therewith, the undersigned and the Company agree as follows:
SUBSCRIPTION AGREEMENTSubscription Agreement • August 2nd, 2019 • Constellation Alpha Capital Corp. • Services-medical laboratories • New York
In connection with the proposed business combination (the “Transaction”) in which DermTech, Inc., a Delaware Corporation (“DermTech”) will merge with a wholly-owned subsidiary corporation of Constellation Alpha Capital Corp., a company incorporated in the British Virgin Islands and which is expected to re-domicile in the State of Delaware (the “Company”), the undersigned desires to subscribe for and purchase from the Company, and the Company desires to sell to the undersigned, that number of shares of common stock (the “Company Shares”) of the Company set forth on the signature page hereof for a purchase price of $3.25 per share, on the terms and subject to the conditions contained herein. In connection therewith, the undersigned and the Company agree as follows:
SUBSCRIPTION AGREEMENTSubscription Agreement • August 2nd, 2019 • Constellation Alpha Capital Corp. • Services-medical laboratories • New York
In connection with the proposed business combination (the “Transaction”) in which DermTech, Inc., a Delaware Corporation (“DermTech”) will merge with a wholly-owned subsidiary corporation of Constellation Alpha Capital Corp., a company incorporated in the British Virgin Islands and which is expected to re-domicile in the State of Delaware (the “Company”), the undersigned desires to subscribe for and purchase from the Company, and the Company desires to sell to the undersigned, that number of shares of common stock (the “Company Shares”) of the Company set forth on the signature page hereof for a purchase price of $3.25 per share, on the terms and subject to the conditions contained herein. In connection therewith, the undersigned and the Company agree as follows:
FIRST AMENDED AND RESTATED SUBSCRIPTION AGREEMENTSubscription Agreement • August 2nd, 2019 • Constellation Alpha Capital Corp. • Services-medical laboratories • New York
This First Amended and Restated Subscription Agreement, which amends and restates in its entirety that certain Subscription Agreement, dated as of May 22, 2019 (as amended, and as may be further amended and/or restated, this “Subscription Agreement”), is made by and between Constellation Alpha Capital Corp., a company incorporated in the British Virgin Islands and which is expected to re-domicile in the State of Delaware (the “Company”), and the undersigned, who desires to subscribe for and purchase from the Company, and the Company desires to sell to the undersigned, that number of (i) shares of common stock (the “Common Shares”) of the Company and (ii) shares of Series A preferred stock (the “Preferred Shares” and, together with the Common Shares, the “Company Shares”) of the Company, where each Preferred Share is convertible into 1,000 Common Shares, set forth on the signature page hereof for a purchase price of $3.25 per Common Share and $3,250 per Preferred Share, on the terms and
FIRST AMENDED AND RESTATED SUBSCRIPTION AGREEMENTSubscription Agreement • August 2nd, 2019 • Constellation Alpha Capital Corp. • Services-medical laboratories • New York
This First Amended and Restated Subscription Agreement, which amends and restates in its entirety that certain Subscription Agreement, dated as of May 22, 2019 (as amended, and as may be further amended and/or restated, this “Subscription Agreement”), is made by and between Constellation Alpha Capital Corp., a company incorporated in the British Virgin Islands and which is expected to re-domicile in the State of Delaware (the “Company”), and the undersigned, who desires to subscribe for and purchase from the Company, and the Company desires to sell to the undersigned, that number of (i) shares of common stock (the “Common Shares”) of the Company and (ii) shares of Series A preferred stock (the “Preferred Shares” and, together with the Common Shares, the “Company Shares”) of the Company, where each Preferred Share is convertible into 1,000 Common Shares, set forth on the signature page hereof for a purchase price of $3.25 per Common Share and $3,250 per Preferred Share, on the terms and
FIRST AMENDED AND RESTATED SUBSCRIPTION AGREEMENTSubscription Agreement • August 2nd, 2019 • Constellation Alpha Capital Corp. • Services-medical laboratories • New York
This First Amended and Restated Subscription Agreement, which amends and restates in its entirety that certain Subscription Agreement, dated as of May 22, 2019 (as amended, and as may be further amended and/or restated, this “Subscription Agreement”), is made by and between Constellation Alpha Capital Corp., a company incorporated in the British Virgin Islands and which is expected to re-domicile in the State of Delaware (the “Company”), and the undersigned, who desires to subscribe for and purchase from the Company, and the Company desires to sell to the undersigned, that number of (i) shares of common stock (the “Common Shares”) of the Company and (ii) shares of Series A preferred stock (the “Preferred Shares” and, together with the Common Shares, the “Company Shares”) of the Company, where each Preferred Share is convertible into 1,000 Common Shares, set forth on the signature page hereof for a purchase price of $3.25 per Common Share and $3,250 per Preferred Share, on the terms and
FIRST AMENDED AND RESTATED SUBSCRIPTION AGREEMENTSubscription Agreement • August 2nd, 2019 • Constellation Alpha Capital Corp. • Services-medical laboratories • New York
This First Amended and Restated Subscription Agreement, which amends and restates in its entirety that certain Subscription Agreement, dated as of May 22, 2019 (as amended, and as may be further amended and/or restated, this “Subscription Agreement”), is made by and between Constellation Alpha Capital Corp., a company incorporated in the British Virgin Islands and which is expected to re-domicile in the State of Delaware (the “Company”), and the undersigned, who desires to subscribe for and purchase from the Company, and the Company desires to sell to the undersigned, that number of (i) shares of common stock (the “Common Shares”) of the Company and (ii) shares of Series A preferred stock (the “Preferred Shares” and, together with the Common Shares, the “Company Shares”) of the Company, where each Preferred Share is convertible into 1,000 Common Shares, set forth on the signature page hereof for a purchase price of $3.25 per Common Share and $3,250 per Preferred Share, on the terms and
FIRST AMENDED AND RESTATED SUBSCRIPTION AGREEMENTSubscription Agreement • August 2nd, 2019 • Constellation Alpha Capital Corp. • Services-medical laboratories • New York
This First Amended and Restated Subscription Agreement, which amends and restates in its entirety that certain Subscription Agreement, dated as of May 22, 2019 (as amended, and as may be further amended and/or restated, this “Subscription Agreement”), is made by and between Constellation Alpha Capital Corp., a company incorporated in the British Virgin Islands and which is expected to re-domicile in the State of Delaware (the “Company”), and the undersigned, who desires to subscribe for and purchase from the Company, and the Company desires to sell to the undersigned, that number of (i) shares of common stock (the “Common Shares”) of the Company and (ii) shares of Series A preferred stock (the “Preferred Shares” and, together with the Common Shares, the “Company Shares”) of the Company, where each Preferred Share is convertible into 1,000 Common Shares, set forth on the signature page hereof for a purchase price of $3.25 per Common Share and $3,250 per Preferred Share, on the terms and
SUBSCRIPTION AGREEMENTSubscription Agreement • May 29th, 2019 • Constellation Alpha Capital Corp. • Services-medical laboratories • New York
In connection with the proposed business combination (the “Transaction”) in which DermTech, Inc., a Delaware Corporation (“DermTech”) will merge with a wholly-owned subsidiary corporation of Constellation Alpha Capital Corp., a company incorporated in the British Virgin Islands and which is expected to re-domicile in the State of Delaware (the “Company”), the undersigned desires to subscribe for and purchase from the Company, and the Company desires to sell to the undersigned, that number of shares of common stock (the “Company Shares”) of the Company set forth on the signature page hereof for a purchase price of $3.25 per share, on the terms and subject to the conditions contained herein. In connection therewith, the undersigned and the Company agree as follows:
